Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Pyrotinib Maleate|DRUG: Dalpiciclib Isethionate Tablets|DRUG: Inetetamab|DRUG: Fulvestrant
Sponsor: Henan Cancer Hospital
Collaborators: Jiangsu HengRui Medicine Co., Ltd.